703 related articles for article (PubMed ID: 7739683)
1. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
3. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
5. [Lambert-Eaton syndrome without calcium channel autoantibodies].
Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
[TBL] [Abstract][Full Text] [Related]
6. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
7. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
[TBL] [Abstract][Full Text] [Related]
9. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
11. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; De Haro L; Seagar M
J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
13. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
15. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
[TBL] [Abstract][Full Text] [Related]
17. [Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
Ferroir JP; Milleron B; Ropert A; Billy C; Nahum L; Tcherakian S; Carette MF
Rev Pneumol Clin; 1999 Jun; 55(3):168-70. PubMed ID: 10486838
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmunity and cancer: paraneoplastic neurological syndromes associated with small cell cancer].
Zenone T
Bull Cancer; 1992; 79(9):837-53. PubMed ID: 1336687
[TBL] [Abstract][Full Text] [Related]
19. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
20. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.
Smith RG; Hamilton S; Hofmann F; Schneider T; Nastainczyk W; Birnbaumer L; Stefani E; Appel SH
N Engl J Med; 1992 Dec; 327(24):1721-8. PubMed ID: 1331790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]